TP53 and cancer: For instance, PAK1 was found to be highly amplified and phosphorylated in breast cancer, which is the cumulative consequence of multiple cancer-related mutations, such as PIK3CA and TP53, and contributes to maintaining the fitness and survival of cancer cells under multiple pressures 27, 28.